Is this FINALLY a cure for insomnia? The new pill which blocks the… | Home | The FDA Has Accepted For Filing The Registration Application For Sublinox

July 30, 2008

Sepracor shares fall as 2nd-quarter profit falls short of forecasts, cut revenue outlook

Shares of drug developer Sepracor Inc. fell Tuesday after the company reported second-quarter profit well below Wall Street forecasts and cut revenue guidance.


From Insomnia News

This entry was posted on Wednesday, July 30th, 2008 at 6:26 am and is filed under Insomnia. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.